UBS raised the firm’s price target on Viavi (VIAV) to $17 from $12 and keeps a Neutral rating on the shares. AI and data center demand drove a strong quarter and guidance, the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VIAV: